UPS Stock Eyes Best Day in Years

The chip sector is propping up the tech-heavy Nasdaq

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MIDDAY MARKET CHECK     7/24/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Dow Pulls Back; Nasdaq Hits a New High By Patrick Martin Share On The Dow Jones Industrial Average (DJI) is taking a breather today, down triple digits as the latest batch of blue-chip earnings reports disappoints. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are cautiously in the black, with the latter fresh off a new record high, as chip sector gains outweigh the scrutiny FAANG stocks are receiving amid news of a U.S. Department of Justice (DOJ) broad antitrust review. Continue reading for more on today's market, including:  Caterpillar stock is contributing to the Dow's struggles today. Why UPS stock is eyeing its best day in years. Plus, call traders eye quick FireEye bounce; Sprint stock soars on T-Mobile merger approval reports; and higher medical costs drop Anthem. >> Continue reading...
LATEST HEADLINES
>> UPS Stock Eyes Best Day in Years on Earnings Beat UPS announced second-quarter earnings and revenue that exceeded analysts' estimates >> Dow Stocks Boeing, Visa In Focus Post-Earnings Our indicators showed a put-skew on Boeing and Visa before earnings >> Dow Futures Sink on Caterpillar Earnings Boeing suffered a major loss of $5.82 per share, while Caterpillar also reported an earnings miss >> Caterpillar Stock Set for Another Post-Earnings Drop The construction giant cited slowing Chinese sales for its earnings miss >> Cannabis Up-and-Comer Focuses on Streamlined Growth This early-staged CBD stock may be setting up investors for big gains. ADVERTISEMENT A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Midday Market Check, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Midday Market Check or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Midday Market Check? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MIDDAY MARKET CHECK enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com